These results reflect the limitation of genetic variations for CAD diagnosis or prediction,42 and suggest that differentially expressed PDGF/PDGFRB mRNAs might be useful biomarkers in assisting CAD discrimination. The gene discussed is PDGFRB; the disease is coronary artery disorder.